Géczi, D.; Klekner, Á.; Balogh, I.; Penyige, A.; Szilágyi, M.; Virga, J.; Bakó, A.; Nagy, B.; Torner, B.; Birkó, Z.
Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. Pharmaceuticals 2025, 18, 431.
https://doi.org/10.3390/ph18030431
AMA Style
Géczi D, Klekner Á, Balogh I, Penyige A, Szilágyi M, Virga J, Bakó A, Nagy B, Torner B, Birkó Z.
Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. Pharmaceuticals. 2025; 18(3):431.
https://doi.org/10.3390/ph18030431
Chicago/Turabian Style
Géczi, Dóra, Álmos Klekner, István Balogh, András Penyige, Melinda Szilágyi, József Virga, Andrea Bakó, Bálint Nagy, Bernadett Torner, and Zsuzsanna Birkó.
2025. "Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing" Pharmaceuticals 18, no. 3: 431.
https://doi.org/10.3390/ph18030431
APA Style
Géczi, D., Klekner, Á., Balogh, I., Penyige, A., Szilágyi, M., Virga, J., Bakó, A., Nagy, B., Torner, B., & Birkó, Z.
(2025). Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. Pharmaceuticals, 18(3), 431.
https://doi.org/10.3390/ph18030431